Librela (bedinvetmab injection) is a monthly injectable monoclonal antibody, for which real-world drug experience data has ...

Dr Arthur Winter, a radiologist at SCP Radiology says, ‘Interventional radiology has developed rapidly. Pain-management ...

Dr. Ilana Etelzon Integrates CompuFlo® Epidural System into Practice Following Positive Clinical ExperienceROSELAND, N.J., Feb. 04, 2025 (GLOBE NEWSWIRE) -- Inc. (NYSE: MLSS), a leading developer of ...

If you spend any time hunched over your phone or your computer or constantly holding tension through your shoulders or jaw, ...

Now a third option is available after the U.S. Food and Drug Administration last week approved Vertex Pharmaceuticals’ Suzetrigine, sold as twice-daily Journavx, a non-addictive prescription drug for ...

The U.S. Food and Drug Administration has approved a novel prescription pain medication that targets sodium channels involved ...

Algiax Pharmaceuticals, a company committed to developing innovative treatments for chronic neuropathic pain, has released ...

New gene therapies could transform sickle cell treatment forever. A future without pain crises or hospitalizations may finally be within reach.

Samaritan Medical Center is closing its Pain Management Center at the end of February because it’s “not meeting the ...

The FDA has approved a new non-opioid prescription medication, Journavx for adults with moderate to severe acute pain.

China Universal Asset Management Co. Ltd. boosted its position in Collegium Pharmaceutical, Inc. (NASDAQ:COLL – Free Report) ...

The new FDA-approved pain drug is suzetrigine, with the brand name Journavx. Suzetrigine is designed to alleviate moderate to ...